Difficulty: Medium
Average Score: 82%
Practice
Radiotherapy is an effective modality of treatment in variable pediatric solid tumors. Of the following, the LEAST responsive tumor to radiotherapy is
Correct answer
D
Rationale
Radiotherapy is a crucial treatment modality for many pediatric solid tumors, but its efficacy varies across different tumor types. In this context, osteosarcoma is the least responsive tumor to radiotherapy among the options provided.
Osteosarcoma is a type of bone cancer that is relatively radioresistant compared to other pediatric solid tumors like rhabdomyosarcoma, neuroblastoma, and nephroblastoma. The dense and mineralized nature of bone tissue makes it harder for radiation to penetrate and effectively target osteosarcoma cells. Additionally, osteosarcoma is often treated primarily with surgery and chemotherapy, as these modalities have shown to be more effective in managing this type of tumor.
Rhabdomyosarcoma, neuroblastoma, and nephroblastoma are more responsive to radiotherapy due to their histological characteristics and the way their cells respond to radiation. These tumors are often part of a multimodal treatment approach that includes radiotherapy alongside surgery and chemotherapy to achieve better outcomes.
In an educational context, understanding the responsiveness of different pediatric solid tumors to radiotherapy is essential for healthcare providers involved in the care of pediatric oncology patients. This knowledge helps in tailoring treatment plans, managing expectations regarding treatment outcomes, and minimizing unnecessary radiation exposure for tumors that are less likely to respond effectively to this modality.
Osteosarcoma is a type of bone cancer that is relatively radioresistant compared to other pediatric solid tumors like rhabdomyosarcoma, neuroblastoma, and nephroblastoma. The dense and mineralized nature of bone tissue makes it harder for radiation to penetrate and effectively target osteosarcoma cells. Additionally, osteosarcoma is often treated primarily with surgery and chemotherapy, as these modalities have shown to be more effective in managing this type of tumor.
Rhabdomyosarcoma, neuroblastoma, and nephroblastoma are more responsive to radiotherapy due to their histological characteristics and the way their cells respond to radiation. These tumors are often part of a multimodal treatment approach that includes radiotherapy alongside surgery and chemotherapy to achieve better outcomes.
In an educational context, understanding the responsiveness of different pediatric solid tumors to radiotherapy is essential for healthcare providers involved in the care of pediatric oncology patients. This knowledge helps in tailoring treatment plans, managing expectations regarding treatment outcomes, and minimizing unnecessary radiation exposure for tumors that are less likely to respond effectively to this modality.